Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China
· Delayed Price · Currency is CNY 15.64
-0.09 (-0.57%)
Apr 29, 2026, 3:04 PM CST
SHE:300233 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 5,933 | 5,307 | 4,552 | 6,336 | 8,741 | 11,167 | Upgrade
|
| Market Cap Growth | -19.42% | 16.58% | -28.16% | -27.51% | -21.73% | 51.12% | Upgrade
|
| Enterprise Value | 5,375 | 5,013 | 4,269 | 5,949 | 8,638 | 10,916 | Upgrade
|
| Last Close Price | 15.64 | 13.99 | 11.70 | 15.93 | 21.61 | 27.41 | Upgrade
|
| PE Ratio | 85.80 | 120.10 | 23.13 | 36.27 | 31.98 | 103.41 | Upgrade
|
| Forward PE | - | 24.24 | 24.24 | 24.24 | 24.24 | 24.24 | Upgrade
|
| PS Ratio | 2.15 | 1.94 | 1.35 | 1.79 | 2.49 | 3.56 | Upgrade
|
| PB Ratio | 1.57 | 1.43 | 1.19 | 1.68 | 2.39 | 3.25 | Upgrade
|
| P/TBV Ratio | 1.87 | 1.70 | 1.40 | 2.00 | 2.77 | 3.79 | Upgrade
|
| P/FCF Ratio | 19.50 | 24.26 | 29.56 | 19.73 | - | 182.94 | Upgrade
|
| P/OCF Ratio | 14.27 | 16.60 | 15.35 | 9.54 | 34.19 | 25.54 | Upgrade
|
| EV/Sales Ratio | 1.94 | 1.83 | 1.26 | 1.68 | 2.46 | 3.48 | Upgrade
|
| EV/EBITDA Ratio | 11.97 | 12.37 | 7.33 | 11.32 | 13.83 | 24.63 | Upgrade
|
| EV/EBIT Ratio | 42.29 | 58.15 | 16.09 | 27.05 | 23.14 | 48.74 | Upgrade
|
| EV/FCF Ratio | 17.66 | 22.92 | 27.72 | 18.52 | - | 178.82 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.10 | 0.14 | 0.15 | 0.18 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 0.75 | 0.93 | 0.88 | 1.05 | 1.03 | 1.46 | Upgrade
|
| Debt / FCF Ratio | 1.11 | 1.74 | 3.35 | 1.73 | - | 10.69 | Upgrade
|
| Net Debt / Equity Ratio | -0.16 | -0.14 | -0.10 | -0.12 | -0.06 | -0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.39 | -1.27 | -0.69 | -0.90 | -0.33 | -0.74 | Upgrade
|
| Net Debt / FCF Ratio | -2.04 | -2.36 | -2.61 | -1.46 | 1.76 | -5.38 | Upgrade
|
| Asset Turnover | 0.52 | 0.51 | 0.59 | 0.60 | 0.63 | 0.61 | Upgrade
|
| Inventory Turnover | 3.51 | 3.41 | 3.76 | 3.84 | 3.98 | 4.57 | Upgrade
|
| Quick Ratio | 1.35 | 1.30 | 1.32 | 1.14 | 0.98 | 1.18 | Upgrade
|
| Current Ratio | 1.73 | 1.71 | 1.84 | 1.48 | 1.36 | 1.51 | Upgrade
|
| Return on Equity (ROE) | 1.71% | 1.12% | 5.46% | 5.20% | 8.05% | 3.56% | Upgrade
|
| Return on Assets (ROA) | 1.49% | 1.00% | 2.88% | 2.34% | 4.20% | 2.73% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.48% | 1.41% | 6.09% | 5.58% | 9.40% | 4.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.20% | 2.20% | 6.10% | 5.10% | 9.10% | 5.80% | Upgrade
|
| Earnings Yield | 1.13% | 0.83% | 4.32% | 2.76% | 3.13% | 0.97% | Upgrade
|
| FCF Yield | 5.13% | 4.12% | 3.38% | 5.07% | -1.35% | 0.55% | Upgrade
|
| Dividend Yield | 1.59% | 1.79% | 2.14% | 1.26% | 0.69% | 0.72% | Upgrade
|
| Payout Ratio | 155.75% | 367.78% | 66.91% | 47.80% | 38.33% | 97.41% | Upgrade
|
| Buyback Yield / Dilution | 3.76% | 2.70% | 2.53% | -0.84% | 0.17% | 0.60% | Upgrade
|
| Total Shareholder Return | 5.33% | 4.48% | 4.67% | 0.42% | 0.86% | 1.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.